nodes	percent_of_prediction	percent_of_DWPC	metapath
Pazopanib—Cytochrome P450 2D6 Inhibitors—Clobazam—epilepsy syndrome	0.465	1	CiPCiCtD
Pazopanib—KDR—epilepsy syndrome	0.083	0.489	CbGaD
Pazopanib—ABCG2—epilepsy syndrome	0.0434	0.256	CbGaD
Pazopanib—CYP2D6—epilepsy syndrome	0.0253	0.149	CbGaD
Pazopanib—ABCB1—epilepsy syndrome	0.018	0.106	CbGaD
Pazopanib—UGT1A1—Propofol—epilepsy syndrome	0.0159	0.0988	CbGbCtD
Pazopanib—CYP2C8—Trimethadione—epilepsy syndrome	0.00826	0.0513	CbGbCtD
Pazopanib—CYP2C8—Fosphenytoin—epilepsy syndrome	0.00777	0.0482	CbGbCtD
Pazopanib—ABCB1—Levetiracetam—epilepsy syndrome	0.00658	0.0408	CbGbCtD
Pazopanib—CYP2C8—Carbamazepine—epilepsy syndrome	0.00558	0.0346	CbGbCtD
Pazopanib—CYP2C8—Primidone—epilepsy syndrome	0.00521	0.0323	CbGbCtD
Pazopanib—CYP2C8—Phenytoin—epilepsy syndrome	0.00501	0.0311	CbGbCtD
Pazopanib—CYP2C8—Propofol—epilepsy syndrome	0.00467	0.029	CbGbCtD
Pazopanib—ABCB1—Clobazam—epilepsy syndrome	0.00456	0.0283	CbGbCtD
Pazopanib—CYP2C8—Phenobarbital—epilepsy syndrome	0.00446	0.0277	CbGbCtD
Pazopanib—ABCB1—Lamotrigine—epilepsy syndrome	0.00439	0.0272	CbGbCtD
Pazopanib—CYP1A2—Carbamazepine—epilepsy syndrome	0.00432	0.0268	CbGbCtD
Pazopanib—CYP2C8—Diazepam—epilepsy syndrome	0.00423	0.0262	CbGbCtD
Pazopanib—CYP1A2—Primidone—epilepsy syndrome	0.00403	0.025	CbGbCtD
Pazopanib—ABCB1—Carbamazepine—epilepsy syndrome	0.00378	0.0234	CbGbCtD
Pazopanib—CYP1A2—Propofol—epilepsy syndrome	0.00361	0.0224	CbGbCtD
Pazopanib—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0036	0.0224	CbGbCtD
Pazopanib—CYP1A2—Phenobarbital—epilepsy syndrome	0.00345	0.0214	CbGbCtD
Pazopanib—ABCB1—Phenytoin—epilepsy syndrome	0.00339	0.021	CbGbCtD
Pazopanib—CYP3A4—Felbamate—epilepsy syndrome	0.00335	0.0208	CbGbCtD
Pazopanib—CYP3A4—Trimethadione—epilepsy syndrome	0.00335	0.0208	CbGbCtD
Pazopanib—CYP2C8—Valproic Acid—epilepsy syndrome	0.00333	0.0207	CbGbCtD
Pazopanib—CYP1A2—Diazepam—epilepsy syndrome	0.00327	0.0203	CbGbCtD
Pazopanib—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00315	0.0195	CbGbCtD
Pazopanib—ABCB1—Phenobarbital—epilepsy syndrome	0.00302	0.0187	CbGbCtD
Pazopanib—ABCB1—Midazolam—epilepsy syndrome	0.00298	0.0185	CbGbCtD
Pazopanib—CYP2D6—Propofol—epilepsy syndrome	0.00298	0.0185	CbGbCtD
Pazopanib—ABCB1—Diazepam—epilepsy syndrome	0.00286	0.0178	CbGbCtD
Pazopanib—CYP3A4—Clonazepam—epilepsy syndrome	0.00285	0.0177	CbGbCtD
Pazopanib—CYP3A4—Clobazam—epilepsy syndrome	0.00273	0.0169	CbGbCtD
Pazopanib—CYP1A2—Valproic Acid—epilepsy syndrome	0.00258	0.016	CbGbCtD
Pazopanib—CYP3A4—Rufinamide—epilepsy syndrome	0.00232	0.0144	CbGbCtD
Pazopanib—CYP3A4—Carbamazepine—epilepsy syndrome	0.00226	0.014	CbGbCtD
Pazopanib—CYP3A4—Primidone—epilepsy syndrome	0.00211	0.0131	CbGbCtD
Pazopanib—CYP3A4—Phenytoin—epilepsy syndrome	0.00203	0.0126	CbGbCtD
Pazopanib—CYP3A4—Propofol—epilepsy syndrome	0.00189	0.0117	CbGbCtD
Pazopanib—CYP3A4—Acetazolamide—epilepsy syndrome	0.00181	0.0112	CbGbCtD
Pazopanib—CYP3A4—Phenobarbital—epilepsy syndrome	0.00181	0.0112	CbGbCtD
Pazopanib—CYP3A4—Midazolam—epilepsy syndrome	0.00178	0.0111	CbGbCtD
Pazopanib—CYP3A4—Diazepam—epilepsy syndrome	0.00172	0.0106	CbGbCtD
Pazopanib—CYP3A4—Zonisamide—epilepsy syndrome	0.00167	0.0104	CbGbCtD
Pazopanib—CYP3A4—Valproic Acid—epilepsy syndrome	0.00135	0.00839	CbGbCtD
Pazopanib—CYP3A4—Topiramate—epilepsy syndrome	0.00122	0.00757	CbGbCtD
Pazopanib—Rilpivirine—ABCG2—epilepsy syndrome	0.000572	0.454	CrCbGaD
Pazopanib—Rilpivirine—CYP2C19—epilepsy syndrome	0.00045	0.357	CrCbGaD
Pazopanib—MAP3K9—midbrain—epilepsy syndrome	0.00037	0.00899	CbGeAlD
Pazopanib—SH2B3—telencephalon—epilepsy syndrome	0.000364	0.00885	CbGeAlD
Pazopanib—TAOK3—hindbrain—epilepsy syndrome	0.000343	0.00833	CbGeAlD
Pazopanib—FGFR3—forebrain—epilepsy syndrome	0.000331	0.00805	CbGeAlD
Pazopanib—MAP3K9—head—epilepsy syndrome	0.000321	0.00779	CbGeAlD
Pazopanib—MAP2K5—hindbrain—epilepsy syndrome	0.000307	0.00747	CbGeAlD
Pazopanib—FGFR3—telencephalon—epilepsy syndrome	0.000305	0.00741	CbGeAlD
Pazopanib—MAP3K9—nervous system—epilepsy syndrome	0.000304	0.00739	CbGeAlD
Pazopanib—TAOK1—medulla oblongata—epilepsy syndrome	0.000304	0.00738	CbGeAlD
Pazopanib—MAP3K9—central nervous system—epilepsy syndrome	0.000293	0.00711	CbGeAlD
Pazopanib—MAP3K9—cerebellum—epilepsy syndrome	0.000286	0.00695	CbGeAlD
Pazopanib—SH2B3—medulla oblongata—epilepsy syndrome	0.000286	0.00695	CbGeAlD
Pazopanib—TAOK1—midbrain—epilepsy syndrome	0.000278	0.00675	CbGeAlD
Pazopanib—KIT—hindbrain—epilepsy syndrome	0.000272	0.00662	CbGeAlD
Pazopanib—TAOK1—spinal cord—epilepsy syndrome	0.000271	0.00658	CbGeAlD
Pazopanib—PI4KB—telencephalon—epilepsy syndrome	0.00027	0.00655	CbGeAlD
Pazopanib—SH2B3—midbrain—epilepsy syndrome	0.000261	0.00635	CbGeAlD
Pazopanib—SH2B3—spinal cord—epilepsy syndrome	0.000255	0.0062	CbGeAlD
Pazopanib—TAOK1—head—epilepsy syndrome	0.000241	0.00585	CbGeAlD
Pazopanib—RIOK2—medulla oblongata—epilepsy syndrome	0.000239	0.00582	CbGeAlD
Pazopanib—FGFR3—medulla oblongata—epilepsy syndrome	0.000239	0.00582	CbGeAlD
Pazopanib—FGF1—brainstem—epilepsy syndrome	0.000238	0.00578	CbGeAlD
Pazopanib—Rilpivirine—ABCB1—epilepsy syndrome	0.000238	0.189	CrCbGaD
Pazopanib—PIP4K2C—telencephalon—epilepsy syndrome	0.000237	0.00575	CbGeAlD
Pazopanib—FGFR1—telencephalon—epilepsy syndrome	0.000235	0.0057	CbGeAlD
Pazopanib—MAP3K9—brain—epilepsy syndrome	0.000232	0.00565	CbGeAlD
Pazopanib—FGF1—forebrain—epilepsy syndrome	0.00023	0.00558	CbGeAlD
Pazopanib—TAOK1—nervous system—epilepsy syndrome	0.000228	0.00555	CbGeAlD
Pazopanib—SH2B3—head—epilepsy syndrome	0.000227	0.00551	CbGeAlD
Pazopanib—FGFR2—brainstem—epilepsy syndrome	0.000225	0.00546	CbGeAlD
Pazopanib—MAP3K2—telencephalon—epilepsy syndrome	0.000224	0.00545	CbGeAlD
Pazopanib—AURKC—head—epilepsy syndrome	0.000223	0.00542	CbGeAlD
Pazopanib—TAOK1—central nervous system—epilepsy syndrome	0.00022	0.00534	CbGeAlD
Pazopanib—FGFR3—midbrain—epilepsy syndrome	0.000219	0.00532	CbGeAlD
Pazopanib—RIOK2—midbrain—epilepsy syndrome	0.000219	0.00532	CbGeAlD
Pazopanib—FGFR2—forebrain—epilepsy syndrome	0.000217	0.00527	CbGeAlD
Pazopanib—STK36—medulla oblongata—epilepsy syndrome	0.000215	0.00523	CbGeAlD
Pazopanib—SH2B3—nervous system—epilepsy syndrome	0.000215	0.00522	CbGeAlD
Pazopanib—TAOK1—cerebellum—epilepsy syndrome	0.000215	0.00522	CbGeAlD
Pazopanib—FGFR3—spinal cord—epilepsy syndrome	0.000214	0.00519	CbGeAlD
Pazopanib—RIOK2—spinal cord—epilepsy syndrome	0.000214	0.00519	CbGeAlD
Pazopanib—PI4KB—medulla oblongata—epilepsy syndrome	0.000212	0.00515	CbGeAlD
Pazopanib—AURKC—nervous system—epilepsy syndrome	0.000212	0.00514	CbGeAlD
Pazopanib—FGF1—telencephalon—epilepsy syndrome	0.000211	0.00513	CbGeAlD
Pazopanib—SH2B3—central nervous system—epilepsy syndrome	0.000207	0.00503	CbGeAlD
Pazopanib—AURKC—central nervous system—epilepsy syndrome	0.000204	0.00495	CbGeAlD
Pazopanib—SH2B3—cerebellum—epilepsy syndrome	0.000202	0.00491	CbGeAlD
Pazopanib—FGFR2—telencephalon—epilepsy syndrome	0.0002	0.00485	CbGeAlD
Pazopanib—EPHB6—forebrain—epilepsy syndrome	0.000199	0.00483	CbGeAlD
Pazopanib—TAOK3—brainstem—epilepsy syndrome	0.000196	0.00477	CbGeAlD
Pazopanib—PI4KB—midbrain—epilepsy syndrome	0.000194	0.0047	CbGeAlD
Pazopanib—STK16—head—epilepsy syndrome	0.000193	0.00468	CbGeAlD
Pazopanib—LYN—head—epilepsy syndrome	0.000191	0.00464	CbGeAlD
Pazopanib—FGFR3—head—epilepsy syndrome	0.00019	0.00461	CbGeAlD
Pazopanib—RIOK2—head—epilepsy syndrome	0.00019	0.00461	CbGeAlD
Pazopanib—TAOK3—forebrain—epilepsy syndrome	0.00019	0.00461	CbGeAlD
Pazopanib—PI4KB—spinal cord—epilepsy syndrome	0.000189	0.00459	CbGeAlD
Pazopanib—PDGFRA—forebrain—epilepsy syndrome	0.000188	0.00458	CbGeAlD
Pazopanib—MAP3K19—head—epilepsy syndrome	0.000188	0.00456	CbGeAlD
Pazopanib—BMPR1B—head—epilepsy syndrome	0.000188	0.00456	CbGeAlD
Pazopanib—PIP4K2C—medulla oblongata—epilepsy syndrome	0.000186	0.00452	CbGeAlD
Pazopanib—LIMK2—spinal cord—epilepsy syndrome	0.000185	0.00451	CbGeAlD
Pazopanib—FLT1—telencephalon—epilepsy syndrome	0.000185	0.00449	CbGeAlD
Pazopanib—FGFR1—medulla oblongata—epilepsy syndrome	0.000184	0.00448	CbGeAlD
Pazopanib—EPHB6—telencephalon—epilepsy syndrome	0.000183	0.00444	CbGeAlD
Pazopanib—STK16—nervous system—epilepsy syndrome	0.000183	0.00444	CbGeAlD
Pazopanib—LYN—nervous system—epilepsy syndrome	0.000181	0.00439	CbGeAlD
Pazopanib—FGFR3—nervous system—epilepsy syndrome	0.00018	0.00437	CbGeAlD
Pazopanib—RIOK2—nervous system—epilepsy syndrome	0.00018	0.00437	CbGeAlD
Pazopanib—MAP3K19—nervous system—epilepsy syndrome	0.000178	0.00433	CbGeAlD
Pazopanib—BMPR1B—nervous system—epilepsy syndrome	0.000178	0.00433	CbGeAlD
Pazopanib—MAP2K5—brainstem—epilepsy syndrome	0.000176	0.00428	CbGeAlD
Pazopanib—STK16—central nervous system—epilepsy syndrome	0.000176	0.00428	CbGeAlD
Pazopanib—TAOK1—brain—epilepsy syndrome	0.000175	0.00424	CbGeAlD
Pazopanib—TAOK3—telencephalon—epilepsy syndrome	0.000174	0.00424	CbGeAlD
Pazopanib—LYN—central nervous system—epilepsy syndrome	0.000174	0.00423	CbGeAlD
Pazopanib—PDGFRA—telencephalon—epilepsy syndrome	0.000173	0.00421	CbGeAlD
Pazopanib—FGFR3—central nervous system—epilepsy syndrome	0.000173	0.00421	CbGeAlD
Pazopanib—RIOK2—central nervous system—epilepsy syndrome	0.000173	0.00421	CbGeAlD
Pazopanib—STK16—cerebellum—epilepsy syndrome	0.000172	0.00418	CbGeAlD
Pazopanib—MAP3K19—central nervous system—epilepsy syndrome	0.000171	0.00417	CbGeAlD
Pazopanib—BMPR1B—central nervous system—epilepsy syndrome	0.000171	0.00417	CbGeAlD
Pazopanib—STK36—head—epilepsy syndrome	0.00017	0.00414	CbGeAlD
Pazopanib—KDR—forebrain—epilepsy syndrome	0.00017	0.00413	CbGeAlD
Pazopanib—PIP4K2C—midbrain—epilepsy syndrome	0.00017	0.00413	CbGeAlD
Pazopanib—FGFR3—cerebellum—epilepsy syndrome	0.000169	0.00411	CbGeAlD
Pazopanib—RIOK2—cerebellum—epilepsy syndrome	0.000169	0.00411	CbGeAlD
Pazopanib—FGFR1—midbrain—epilepsy syndrome	0.000168	0.00409	CbGeAlD
Pazopanib—PI4KB—head—epilepsy syndrome	0.000168	0.00408	CbGeAlD
Pazopanib—BMPR1B—cerebellum—epilepsy syndrome	0.000168	0.00407	CbGeAlD
Pazopanib—FGF1—medulla oblongata—epilepsy syndrome	0.000166	0.00403	CbGeAlD
Pazopanib—CSF1R—forebrain—epilepsy syndrome	0.000166	0.00403	CbGeAlD
Pazopanib—PIP4K2C—spinal cord—epilepsy syndrome	0.000166	0.00403	CbGeAlD
Pazopanib—LIMK2—head—epilepsy syndrome	0.000165	0.004	CbGeAlD
Pazopanib—FGFR1—spinal cord—epilepsy syndrome	0.000164	0.00399	CbGeAlD
Pazopanib—SH2B3—brain—epilepsy syndrome	0.000164	0.00399	CbGeAlD
Pazopanib—AURKC—brain—epilepsy syndrome	0.000162	0.00393	CbGeAlD
Pazopanib—STK36—nervous system—epilepsy syndrome	0.000162	0.00393	CbGeAlD
Pazopanib—PI4KB—nervous system—epilepsy syndrome	0.000159	0.00387	CbGeAlD
Pazopanib—MAP2K5—telencephalon—epilepsy syndrome	0.000156	0.0038	CbGeAlD
Pazopanib—LIMK2—nervous system—epilepsy syndrome	0.000156	0.0038	CbGeAlD
Pazopanib—KIT—brainstem—epilepsy syndrome	0.000156	0.00379	CbGeAlD
Pazopanib—STK36—central nervous system—epilepsy syndrome	0.000156	0.00378	CbGeAlD
Pazopanib—PI4KB—central nervous system—epilepsy syndrome	0.000153	0.00372	CbGeAlD
Pazopanib—CSF1R—telencephalon—epilepsy syndrome	0.000153	0.00371	CbGeAlD
Pazopanib—STK36—cerebellum—epilepsy syndrome	0.000152	0.0037	CbGeAlD
Pazopanib—FGF1—midbrain—epilepsy syndrome	0.000152	0.00369	CbGeAlD
Pazopanib—LIMK2—central nervous system—epilepsy syndrome	0.00015	0.00366	CbGeAlD
Pazopanib—PI4KB—cerebellum—epilepsy syndrome	0.00015	0.00364	CbGeAlD
Pazopanib—FLT4—head—epilepsy syndrome	0.000148	0.0036	CbGeAlD
Pazopanib—FGF1—spinal cord—epilepsy syndrome	0.000148	0.0036	CbGeAlD
Pazopanib—PLK4—brain—epilepsy syndrome	0.000148	0.00359	CbGeAlD
Pazopanib—PIP4K2C—head—epilepsy syndrome	0.000147	0.00358	CbGeAlD
Pazopanib—LIMK2—cerebellum—epilepsy syndrome	0.000147	0.00357	CbGeAlD
Pazopanib—FLT1—medulla oblongata—epilepsy syndrome	0.000145	0.00353	CbGeAlD
Pazopanib—EPHB6—medulla oblongata—epilepsy syndrome	0.000144	0.00349	CbGeAlD
Pazopanib—FGFR2—spinal cord—epilepsy syndrome	0.00014	0.0034	CbGeAlD
Pazopanib—STK16—brain—epilepsy syndrome	0.00014	0.00339	CbGeAlD
Pazopanib—PIP4K2C—nervous system—epilepsy syndrome	0.00014	0.00339	CbGeAlD
Pazopanib—MAP3K2—head—epilepsy syndrome	0.00014	0.00339	CbGeAlD
Pazopanib—KIT—telencephalon—epilepsy syndrome	0.000139	0.00337	CbGeAlD
Pazopanib—LYN—brain—epilepsy syndrome	0.000138	0.00336	CbGeAlD
Pazopanib—RIOK2—brain—epilepsy syndrome	0.000138	0.00334	CbGeAlD
Pazopanib—FGFR3—brain—epilepsy syndrome	0.000138	0.00334	CbGeAlD
Pazopanib—TAOK3—medulla oblongata—epilepsy syndrome	0.000137	0.00333	CbGeAlD
Pazopanib—MAP3K19—brain—epilepsy syndrome	0.000136	0.00331	CbGeAlD
Pazopanib—BMPR1B—brain—epilepsy syndrome	0.000136	0.00331	CbGeAlD
Pazopanib—PDGFRB—telencephalon—epilepsy syndrome	0.000135	0.00329	CbGeAlD
Pazopanib—PIP4K2C—central nervous system—epilepsy syndrome	0.000134	0.00327	CbGeAlD
Pazopanib—FLT1—midbrain—epilepsy syndrome	0.000133	0.00323	CbGeAlD
Pazopanib—MAP3K2—nervous system—epilepsy syndrome	0.000132	0.00322	CbGeAlD
Pazopanib—FGF1—head—epilepsy syndrome	0.000132	0.0032	CbGeAlD
Pazopanib—PIP4K2C—cerebellum—epilepsy syndrome	0.000131	0.00319	CbGeAlD
Pazopanib—EPHB6—midbrain—epilepsy syndrome	0.000131	0.00319	CbGeAlD
Pazopanib—FGFR1—cerebellum—epilepsy syndrome	0.00013	0.00317	CbGeAlD
Pazopanib—FLT1—spinal cord—epilepsy syndrome	0.00013	0.00315	CbGeAlD
Pazopanib—EPHB6—spinal cord—epilepsy syndrome	0.000128	0.00311	CbGeAlD
Pazopanib—MAP3K2—central nervous system—epilepsy syndrome	0.000127	0.0031	CbGeAlD
Pazopanib—TAOK3—midbrain—epilepsy syndrome	0.000125	0.00304	CbGeAlD
Pazopanib—FGF1—nervous system—epilepsy syndrome	0.000125	0.00303	CbGeAlD
Pazopanib—MAP3K2—cerebellum—epilepsy syndrome	0.000125	0.00303	CbGeAlD
Pazopanib—FGFR2—head—epilepsy syndrome	0.000124	0.00302	CbGeAlD
Pazopanib—STK36—brain—epilepsy syndrome	0.000124	0.003	CbGeAlD
Pazopanib—KDR—medulla oblongata—epilepsy syndrome	0.000123	0.00298	CbGeAlD
Pazopanib—MAP2K5—medulla oblongata—epilepsy syndrome	0.000123	0.00298	CbGeAlD
Pazopanib—TAOK3—spinal cord—epilepsy syndrome	0.000122	0.00297	CbGeAlD
Pazopanib—PI4KB—brain—epilepsy syndrome	0.000122	0.00296	CbGeAlD
Pazopanib—PDGFRA—spinal cord—epilepsy syndrome	0.000121	0.00295	CbGeAlD
Pazopanib—FGF1—central nervous system—epilepsy syndrome	0.00012	0.00292	CbGeAlD
Pazopanib—CSF1R—medulla oblongata—epilepsy syndrome	0.00012	0.00291	CbGeAlD
Pazopanib—LIMK2—brain—epilepsy syndrome	0.000119	0.0029	CbGeAlD
Pazopanib—FGFR2—nervous system—epilepsy syndrome	0.000118	0.00286	CbGeAlD
Pazopanib—FGF1—cerebellum—epilepsy syndrome	0.000117	0.00285	CbGeAlD
Pazopanib—FLT1—head—epilepsy syndrome	0.000115	0.0028	CbGeAlD
Pazopanib—EPHB6—head—epilepsy syndrome	0.000114	0.00277	CbGeAlD
Pazopanib—FGFR2—central nervous system—epilepsy syndrome	0.000113	0.00276	CbGeAlD
Pazopanib—MAP2K5—midbrain—epilepsy syndrome	0.000112	0.00273	CbGeAlD
Pazopanib—KDR—midbrain—epilepsy syndrome	0.000112	0.00273	CbGeAlD
Pazopanib—FGFR2—cerebellum—epilepsy syndrome	0.000111	0.00269	CbGeAlD
Pazopanib—CSF1R—midbrain—epilepsy syndrome	0.00011	0.00266	CbGeAlD
Pazopanib—MAP2K5—spinal cord—epilepsy syndrome	0.00011	0.00266	CbGeAlD
Pazopanib—KDR—spinal cord—epilepsy syndrome	0.00011	0.00266	CbGeAlD
Pazopanib—FLT1—nervous system—epilepsy syndrome	0.000109	0.00265	CbGeAlD
Pazopanib—STK10—head—epilepsy syndrome	0.000109	0.00265	CbGeAlD
Pazopanib—KIT—medulla oblongata—epilepsy syndrome	0.000109	0.00264	CbGeAlD
Pazopanib—TAOK3—head—epilepsy syndrome	0.000109	0.00264	CbGeAlD
Pazopanib—EPHB6—nervous system—epilepsy syndrome	0.000108	0.00262	CbGeAlD
Pazopanib—PDGFRA—head—epilepsy syndrome	0.000108	0.00262	CbGeAlD
Pazopanib—FLT4—brain—epilepsy syndrome	0.000107	0.00261	CbGeAlD
Pazopanib—CSF1R—spinal cord—epilepsy syndrome	0.000107	0.0026	CbGeAlD
Pazopanib—PIP4K2C—brain—epilepsy syndrome	0.000107	0.00259	CbGeAlD
Pazopanib—PDGFRB—medulla oblongata—epilepsy syndrome	0.000106	0.00258	CbGeAlD
Pazopanib—FGFR1—brain—epilepsy syndrome	0.000106	0.00257	CbGeAlD
Pazopanib—FLT1—central nervous system—epilepsy syndrome	0.000105	0.00255	CbGeAlD
Pazopanib—EPHB6—central nervous system—epilepsy syndrome	0.000104	0.00252	CbGeAlD
Pazopanib—STK10—nervous system—epilepsy syndrome	0.000103	0.00251	CbGeAlD
Pazopanib—TAOK3—nervous system—epilepsy syndrome	0.000103	0.0025	CbGeAlD
Pazopanib—FLT1—cerebellum—epilepsy syndrome	0.000103	0.0025	CbGeAlD
Pazopanib—CYP2D6—hindbrain—epilepsy syndrome	0.000102	0.00249	CbGeAlD
Pazopanib—PDGFRA—nervous system—epilepsy syndrome	0.000102	0.00249	CbGeAlD
Pazopanib—EPHB6—cerebellum—epilepsy syndrome	0.000102	0.00247	CbGeAlD
Pazopanib—MAP3K2—brain—epilepsy syndrome	0.000101	0.00246	CbGeAlD
Pazopanib—STK10—central nervous system—epilepsy syndrome	9.95e-05	0.00242	CbGeAlD
Pazopanib—KIT—midbrain—epilepsy syndrome	9.95e-05	0.00242	CbGeAlD
Pazopanib—TAOK3—central nervous system—epilepsy syndrome	9.91e-05	0.00241	CbGeAlD
Pazopanib—PDGFRA—central nervous system—epilepsy syndrome	9.85e-05	0.00239	CbGeAlD
Pazopanib—KDR—head—epilepsy syndrome	9.73e-05	0.00237	CbGeAlD
Pazopanib—MAP2K5—head—epilepsy syndrome	9.73e-05	0.00237	CbGeAlD
Pazopanib—STK10—cerebellum—epilepsy syndrome	9.72e-05	0.00236	CbGeAlD
Pazopanib—PDGFRB—midbrain—epilepsy syndrome	9.72e-05	0.00236	CbGeAlD
Pazopanib—KIT—spinal cord—epilepsy syndrome	9.71e-05	0.00236	CbGeAlD
Pazopanib—TAOK3—cerebellum—epilepsy syndrome	9.69e-05	0.00235	CbGeAlD
Pazopanib—PDGFRA—cerebellum—epilepsy syndrome	9.63e-05	0.00234	CbGeAlD
Pazopanib—FGF1—brain—epilepsy syndrome	9.53e-05	0.00232	CbGeAlD
Pazopanib—CSF1R—head—epilepsy syndrome	9.5e-05	0.00231	CbGeAlD
Pazopanib—PDGFRB—spinal cord—epilepsy syndrome	9.48e-05	0.0023	CbGeAlD
Pazopanib—KDR—nervous system—epilepsy syndrome	9.23e-05	0.00224	CbGeAlD
Pazopanib—MAP2K5—nervous system—epilepsy syndrome	9.23e-05	0.00224	CbGeAlD
Pazopanib—CSF1R—nervous system—epilepsy syndrome	9.01e-05	0.00219	CbGeAlD
Pazopanib—FGFR2—brain—epilepsy syndrome	9e-05	0.00219	CbGeAlD
Pazopanib—KDR—central nervous system—epilepsy syndrome	8.89e-05	0.00216	CbGeAlD
Pazopanib—MAP2K5—central nervous system—epilepsy syndrome	8.89e-05	0.00216	CbGeAlD
Pazopanib—KDR—cerebellum—epilepsy syndrome	8.68e-05	0.00211	CbGeAlD
Pazopanib—MAP2K5—cerebellum—epilepsy syndrome	8.68e-05	0.00211	CbGeAlD
Pazopanib—CSF1R—central nervous system—epilepsy syndrome	8.67e-05	0.00211	CbGeAlD
Pazopanib—KIT—head—epilepsy syndrome	8.63e-05	0.0021	CbGeAlD
Pazopanib—CSF1R—cerebellum—epilepsy syndrome	8.48e-05	0.00206	CbGeAlD
Pazopanib—PDGFRB—head—epilepsy syndrome	8.43e-05	0.00205	CbGeAlD
Pazopanib—FLT1—brain—epilepsy syndrome	8.34e-05	0.00203	CbGeAlD
Pazopanib—EPHB6—brain—epilepsy syndrome	8.25e-05	0.002	CbGeAlD
Pazopanib—KIT—nervous system—epilepsy syndrome	8.18e-05	0.00199	CbGeAlD
Pazopanib—PDGFRB—nervous system—epilepsy syndrome	7.99e-05	0.00194	CbGeAlD
Pazopanib—STK10—brain—epilepsy syndrome	7.9e-05	0.00192	CbGeAlD
Pazopanib—KIT—central nervous system—epilepsy syndrome	7.87e-05	0.00191	CbGeAlD
Pazopanib—TAOK3—brain—epilepsy syndrome	7.87e-05	0.00191	CbGeAlD
Pazopanib—PDGFRA—brain—epilepsy syndrome	7.82e-05	0.0019	CbGeAlD
Pazopanib—KIT—cerebellum—epilepsy syndrome	7.7e-05	0.00187	CbGeAlD
Pazopanib—PDGFRB—central nervous system—epilepsy syndrome	7.69e-05	0.00187	CbGeAlD
Pazopanib—ABCG2—telencephalon—epilepsy syndrome	7.6e-05	0.00185	CbGeAlD
Pazopanib—PDGFRB—cerebellum—epilepsy syndrome	7.52e-05	0.00183	CbGeAlD
Pazopanib—MAP2K5—brain—epilepsy syndrome	7.05e-05	0.00171	CbGeAlD
Pazopanib—KDR—brain—epilepsy syndrome	7.05e-05	0.00171	CbGeAlD
Pazopanib—CSF1R—brain—epilepsy syndrome	6.88e-05	0.00167	CbGeAlD
Pazopanib—KIT—brain—epilepsy syndrome	6.25e-05	0.00152	CbGeAlD
Pazopanib—PDGFRB—brain—epilepsy syndrome	6.11e-05	0.00148	CbGeAlD
Pazopanib—ABCG2—medulla oblongata—epilepsy syndrome	5.98e-05	0.00145	CbGeAlD
Pazopanib—CYP2D6—brainstem—epilepsy syndrome	5.87e-05	0.00143	CbGeAlD
Pazopanib—CYP2D6—forebrain—epilepsy syndrome	5.67e-05	0.00138	CbGeAlD
Pazopanib—ABCG2—midbrain—epilepsy syndrome	5.46e-05	0.00133	CbGeAlD
Pazopanib—ABCG2—spinal cord—epilepsy syndrome	5.33e-05	0.00129	CbGeAlD
Pazopanib—CYP2D6—telencephalon—epilepsy syndrome	5.21e-05	0.00127	CbGeAlD
Pazopanib—ABCG2—cerebellum—epilepsy syndrome	4.22e-05	0.00103	CbGeAlD
Pazopanib—ABCB1—forebrain—epilepsy syndrome	4.08e-05	0.000991	CbGeAlD
Pazopanib—ABCB1—telencephalon—epilepsy syndrome	3.75e-05	0.000911	CbGeAlD
Pazopanib—CYP2C8—brain—epilepsy syndrome	3.53e-05	0.000858	CbGeAlD
Pazopanib—ABCG2—brain—epilepsy syndrome	3.43e-05	0.000834	CbGeAlD
Pazopanib—CYP2D6—head—epilepsy syndrome	3.25e-05	0.000789	CbGeAlD
Pazopanib—CYP3A4—nervous system—epilepsy syndrome	3.13e-05	0.00076	CbGeAlD
Pazopanib—CYP2D6—nervous system—epilepsy syndrome	3.08e-05	0.000748	CbGeAlD
Pazopanib—CYP3A4—central nervous system—epilepsy syndrome	3.01e-05	0.000732	CbGeAlD
Pazopanib—CYP2D6—central nervous system—epilepsy syndrome	2.96e-05	0.00072	CbGeAlD
Pazopanib—ABCB1—medulla oblongata—epilepsy syndrome	2.95e-05	0.000716	CbGeAlD
Pazopanib—CYP2D6—cerebellum—epilepsy syndrome	2.9e-05	0.000704	CbGeAlD
Pazopanib—ABCB1—midbrain—epilepsy syndrome	2.69e-05	0.000654	CbGeAlD
Pazopanib—ABCB1—spinal cord—epilepsy syndrome	2.63e-05	0.000638	CbGeAlD
Pazopanib—Oedema—Valproic Acid—epilepsy syndrome	2.48e-05	0.000283	CcSEcCtD
Pazopanib—Bradycardia—Topiramate—epilepsy syndrome	2.48e-05	0.000283	CcSEcCtD
Pazopanib—Nausea—Propofol—epilepsy syndrome	2.48e-05	0.000283	CcSEcCtD
Pazopanib—Vomiting—Fosphenytoin—epilepsy syndrome	2.47e-05	0.000282	CcSEcCtD
Pazopanib—Diarrhoea—Felbamate—epilepsy syndrome	2.47e-05	0.000282	CcSEcCtD
Pazopanib—Abdominal pain—Lamotrigine—epilepsy syndrome	2.47e-05	0.000282	CcSEcCtD
Pazopanib—Dysgeusia—Gabapentin—epilepsy syndrome	2.47e-05	0.000282	CcSEcCtD
Pazopanib—Dizziness—Diazepam—epilepsy syndrome	2.47e-05	0.000282	CcSEcCtD
Pazopanib—Infection—Valproic Acid—epilepsy syndrome	2.47e-05	0.000281	CcSEcCtD
Pazopanib—Syncope—Pregabalin—epilepsy syndrome	2.47e-05	0.000281	CcSEcCtD
Pazopanib—Leukopenia—Pregabalin—epilepsy syndrome	2.46e-05	0.000281	CcSEcCtD
Pazopanib—Rash—Fosphenytoin—epilepsy syndrome	2.45e-05	0.00028	CcSEcCtD
Pazopanib—Dermatitis—Fosphenytoin—epilepsy syndrome	2.45e-05	0.00028	CcSEcCtD
Pazopanib—Haemoglobin—Topiramate—epilepsy syndrome	2.45e-05	0.000279	CcSEcCtD
Pazopanib—Asthenia—Clonazepam—epilepsy syndrome	2.45e-05	0.000279	CcSEcCtD
Pazopanib—Headache—Fosphenytoin—epilepsy syndrome	2.44e-05	0.000278	CcSEcCtD
Pazopanib—Haemorrhage—Topiramate—epilepsy syndrome	2.44e-05	0.000278	CcSEcCtD
Pazopanib—Nervous system disorder—Valproic Acid—epilepsy syndrome	2.44e-05	0.000278	CcSEcCtD
Pazopanib—Thrombocytopenia—Valproic Acid—epilepsy syndrome	2.43e-05	0.000277	CcSEcCtD
Pazopanib—Asthenia—Phenytoin—epilepsy syndrome	2.43e-05	0.000277	CcSEcCtD
Pazopanib—Nausea—Midazolam—epilepsy syndrome	2.43e-05	0.000277	CcSEcCtD
Pazopanib—Hypoaesthesia—Topiramate—epilepsy syndrome	2.43e-05	0.000277	CcSEcCtD
Pazopanib—Muscle spasms—Gabapentin—epilepsy syndrome	2.43e-05	0.000276	CcSEcCtD
Pazopanib—Diarrhoea—Zonisamide—epilepsy syndrome	2.42e-05	0.000276	CcSEcCtD
Pazopanib—Loss of consciousness—Pregabalin—epilepsy syndrome	2.42e-05	0.000276	CcSEcCtD
Pazopanib—Asthenia—Oxcarbazepine—epilepsy syndrome	2.42e-05	0.000276	CcSEcCtD
Pazopanib—Pruritus—Clonazepam—epilepsy syndrome	2.41e-05	0.000275	CcSEcCtD
Pazopanib—Vomiting—Vigabatrin—epilepsy syndrome	2.41e-05	0.000275	CcSEcCtD
Pazopanib—Skin disorder—Valproic Acid—epilepsy syndrome	2.41e-05	0.000275	CcSEcCtD
Pazopanib—Urinary tract disorder—Topiramate—epilepsy syndrome	2.41e-05	0.000274	CcSEcCtD
Pazopanib—Oedema peripheral—Topiramate—epilepsy syndrome	2.4e-05	0.000274	CcSEcCtD
Pazopanib—Hyperhidrosis—Valproic Acid—epilepsy syndrome	2.4e-05	0.000274	CcSEcCtD
Pazopanib—Cough—Pregabalin—epilepsy syndrome	2.4e-05	0.000274	CcSEcCtD
Pazopanib—Pruritus—Phenytoin—epilepsy syndrome	2.4e-05	0.000273	CcSEcCtD
Pazopanib—Connective tissue disorder—Topiramate—epilepsy syndrome	2.4e-05	0.000273	CcSEcCtD
Pazopanib—Nausea—Levetiracetam—epilepsy syndrome	2.4e-05	0.000273	CcSEcCtD
Pazopanib—Rash—Vigabatrin—epilepsy syndrome	2.39e-05	0.000273	CcSEcCtD
Pazopanib—Dizziness—Felbamate—epilepsy syndrome	2.39e-05	0.000273	CcSEcCtD
Pazopanib—Dermatitis—Vigabatrin—epilepsy syndrome	2.39e-05	0.000272	CcSEcCtD
Pazopanib—Urethral disorder—Topiramate—epilepsy syndrome	2.39e-05	0.000272	CcSEcCtD
Pazopanib—Pruritus—Oxcarbazepine—epilepsy syndrome	2.38e-05	0.000272	CcSEcCtD
Pazopanib—Vision blurred—Gabapentin—epilepsy syndrome	2.38e-05	0.000271	CcSEcCtD
Pazopanib—Headache—Vigabatrin—epilepsy syndrome	2.38e-05	0.000271	CcSEcCtD
Pazopanib—Hypertension—Pregabalin—epilepsy syndrome	2.37e-05	0.000271	CcSEcCtD
Pazopanib—Vomiting—Diazepam—epilepsy syndrome	2.37e-05	0.000271	CcSEcCtD
Pazopanib—Anorexia—Valproic Acid—epilepsy syndrome	2.37e-05	0.00027	CcSEcCtD
Pazopanib—Rash—Diazepam—epilepsy syndrome	2.35e-05	0.000268	CcSEcCtD
Pazopanib—Dermatitis—Diazepam—epilepsy syndrome	2.35e-05	0.000268	CcSEcCtD
Pazopanib—CYP2D6—brain—epilepsy syndrome	2.35e-05	0.000572	CbGeAlD
Pazopanib—Arthralgia—Pregabalin—epilepsy syndrome	2.34e-05	0.000267	CcSEcCtD
Pazopanib—Chest pain—Pregabalin—epilepsy syndrome	2.34e-05	0.000267	CcSEcCtD
Pazopanib—Myalgia—Pregabalin—epilepsy syndrome	2.34e-05	0.000267	CcSEcCtD
Pazopanib—Dizziness—Zonisamide—epilepsy syndrome	2.34e-05	0.000267	CcSEcCtD
Pazopanib—Headache—Diazepam—epilepsy syndrome	2.34e-05	0.000267	CcSEcCtD
Pazopanib—ABCB1—head—epilepsy syndrome	2.34e-05	0.000567	CbGeAlD
Pazopanib—Diarrhoea—Clonazepam—epilepsy syndrome	2.33e-05	0.000266	CcSEcCtD
Pazopanib—Anaemia—Gabapentin—epilepsy syndrome	2.33e-05	0.000266	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	2.33e-05	0.000265	CcSEcCtD
Pazopanib—Asthenia—Carbamazepine—epilepsy syndrome	2.32e-05	0.000264	CcSEcCtD
Pazopanib—Diarrhoea—Phenytoin—epilepsy syndrome	2.32e-05	0.000264	CcSEcCtD
Pazopanib—Nausea—Fosphenytoin—epilepsy syndrome	2.31e-05	0.000264	CcSEcCtD
Pazopanib—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2.31e-05	0.000263	CcSEcCtD
Pazopanib—Vomiting—Felbamate—epilepsy syndrome	2.3e-05	0.000262	CcSEcCtD
Pazopanib—Dry mouth—Pregabalin—epilepsy syndrome	2.29e-05	0.000261	CcSEcCtD
Pazopanib—Pruritus—Carbamazepine—epilepsy syndrome	2.29e-05	0.000261	CcSEcCtD
Pazopanib—Rash—Felbamate—epilepsy syndrome	2.28e-05	0.00026	CcSEcCtD
Pazopanib—Eye disorder—Topiramate—epilepsy syndrome	2.28e-05	0.00026	CcSEcCtD
Pazopanib—Dermatitis—Felbamate—epilepsy syndrome	2.28e-05	0.00026	CcSEcCtD
Pazopanib—Headache—Felbamate—epilepsy syndrome	2.26e-05	0.000258	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	2.26e-05	0.000258	CcSEcCtD
Pazopanib—Flushing—Topiramate—epilepsy syndrome	2.26e-05	0.000258	CcSEcCtD
Pazopanib—Cardiac disorder—Topiramate—epilepsy syndrome	2.26e-05	0.000258	CcSEcCtD
Pazopanib—Syncope—Gabapentin—epilepsy syndrome	2.26e-05	0.000258	CcSEcCtD
Pazopanib—Leukopenia—Gabapentin—epilepsy syndrome	2.26e-05	0.000257	CcSEcCtD
Pazopanib—Dizziness—Clonazepam—epilepsy syndrome	2.26e-05	0.000257	CcSEcCtD
Pazopanib—Nausea—Vigabatrin—epilepsy syndrome	2.25e-05	0.000257	CcSEcCtD
Pazopanib—Vomiting—Zonisamide—epilepsy syndrome	2.25e-05	0.000256	CcSEcCtD
Pazopanib—Insomnia—Valproic Acid—epilepsy syndrome	2.25e-05	0.000256	CcSEcCtD
Pazopanib—Oedema—Pregabalin—epilepsy syndrome	2.24e-05	0.000256	CcSEcCtD
Pazopanib—Asthenia—Lamotrigine—epilepsy syndrome	2.24e-05	0.000256	CcSEcCtD
Pazopanib—Dizziness—Phenytoin—epilepsy syndrome	2.24e-05	0.000255	CcSEcCtD
Pazopanib—Rash—Zonisamide—epilepsy syndrome	2.23e-05	0.000254	CcSEcCtD
Pazopanib—Infection—Pregabalin—epilepsy syndrome	2.23e-05	0.000254	CcSEcCtD
Pazopanib—Paraesthesia—Valproic Acid—epilepsy syndrome	2.23e-05	0.000254	CcSEcCtD
Pazopanib—Dermatitis—Zonisamide—epilepsy syndrome	2.23e-05	0.000254	CcSEcCtD
Pazopanib—Dizziness—Oxcarbazepine—epilepsy syndrome	2.23e-05	0.000254	CcSEcCtD
Pazopanib—Nausea—Diazepam—epilepsy syndrome	2.22e-05	0.000253	CcSEcCtD
Pazopanib—Loss of consciousness—Gabapentin—epilepsy syndrome	2.22e-05	0.000253	CcSEcCtD
Pazopanib—Headache—Zonisamide—epilepsy syndrome	2.22e-05	0.000253	CcSEcCtD
Pazopanib—ABCB1—nervous system—epilepsy syndrome	2.21e-05	0.000538	CbGeAlD
Pazopanib—Dyspnoea—Valproic Acid—epilepsy syndrome	2.21e-05	0.000252	CcSEcCtD
Pazopanib—Diarrhoea—Carbamazepine—epilepsy syndrome	2.21e-05	0.000252	CcSEcCtD
Pazopanib—Angiopathy—Topiramate—epilepsy syndrome	2.21e-05	0.000252	CcSEcCtD
Pazopanib—Pruritus—Lamotrigine—epilepsy syndrome	2.21e-05	0.000252	CcSEcCtD
Pazopanib—Shock—Pregabalin—epilepsy syndrome	2.21e-05	0.000252	CcSEcCtD
Pazopanib—Somnolence—Valproic Acid—epilepsy syndrome	2.21e-05	0.000252	CcSEcCtD
Pazopanib—Nervous system disorder—Pregabalin—epilepsy syndrome	2.2e-05	0.000251	CcSEcCtD
Pazopanib—Cough—Gabapentin—epilepsy syndrome	2.2e-05	0.000251	CcSEcCtD
Pazopanib—Thrombocytopenia—Pregabalin—epilepsy syndrome	2.2e-05	0.000251	CcSEcCtD
Pazopanib—Mediastinal disorder—Topiramate—epilepsy syndrome	2.2e-05	0.00025	CcSEcCtD
Pazopanib—Chills—Topiramate—epilepsy syndrome	2.19e-05	0.000249	CcSEcCtD
Pazopanib—Dyspepsia—Valproic Acid—epilepsy syndrome	2.19e-05	0.000249	CcSEcCtD
Pazopanib—Skin disorder—Pregabalin—epilepsy syndrome	2.18e-05	0.000249	CcSEcCtD
Pazopanib—Hypertension—Gabapentin—epilepsy syndrome	2.18e-05	0.000248	CcSEcCtD
Pazopanib—Hyperhidrosis—Pregabalin—epilepsy syndrome	2.17e-05	0.000247	CcSEcCtD
Pazopanib—Vomiting—Clonazepam—epilepsy syndrome	2.17e-05	0.000247	CcSEcCtD
Pazopanib—Decreased appetite—Valproic Acid—epilepsy syndrome	2.16e-05	0.000246	CcSEcCtD
Pazopanib—Alopecia—Topiramate—epilepsy syndrome	2.15e-05	0.000246	CcSEcCtD
Pazopanib—Vomiting—Phenytoin—epilepsy syndrome	2.15e-05	0.000246	CcSEcCtD
Pazopanib—Rash—Clonazepam—epilepsy syndrome	2.15e-05	0.000245	CcSEcCtD
Pazopanib—Dermatitis—Clonazepam—epilepsy syndrome	2.15e-05	0.000245	CcSEcCtD
Pazopanib—Chest pain—Gabapentin—epilepsy syndrome	2.15e-05	0.000245	CcSEcCtD
Pazopanib—Myalgia—Gabapentin—epilepsy syndrome	2.15e-05	0.000245	CcSEcCtD
Pazopanib—Arthralgia—Gabapentin—epilepsy syndrome	2.15e-05	0.000245	CcSEcCtD
Pazopanib—Nausea—Felbamate—epilepsy syndrome	2.15e-05	0.000245	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	2.14e-05	0.000244	CcSEcCtD
Pazopanib—Vomiting—Oxcarbazepine—epilepsy syndrome	2.14e-05	0.000244	CcSEcCtD
Pazopanib—Fatigue—Valproic Acid—epilepsy syndrome	2.14e-05	0.000244	CcSEcCtD
Pazopanib—Anorexia—Pregabalin—epilepsy syndrome	2.14e-05	0.000244	CcSEcCtD
Pazopanib—Dizziness—Carbamazepine—epilepsy syndrome	2.14e-05	0.000244	CcSEcCtD
Pazopanib—Diarrhoea—Lamotrigine—epilepsy syndrome	2.14e-05	0.000244	CcSEcCtD
Pazopanib—Headache—Clonazepam—epilepsy syndrome	2.14e-05	0.000244	CcSEcCtD
Pazopanib—Rash—Phenytoin—epilepsy syndrome	2.14e-05	0.000244	CcSEcCtD
Pazopanib—Mental disorder—Topiramate—epilepsy syndrome	2.14e-05	0.000243	CcSEcCtD
Pazopanib—Dermatitis—Phenytoin—epilepsy syndrome	2.13e-05	0.000243	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	2.13e-05	0.000243	CcSEcCtD
Pazopanib—ABCB1—central nervous system—epilepsy syndrome	2.13e-05	0.000518	CbGeAlD
Pazopanib—Rash—Oxcarbazepine—epilepsy syndrome	2.12e-05	0.000242	CcSEcCtD
Pazopanib—Pain—Valproic Acid—epilepsy syndrome	2.12e-05	0.000242	CcSEcCtD
Pazopanib—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.12e-05	0.000242	CcSEcCtD
Pazopanib—Headache—Phenytoin—epilepsy syndrome	2.12e-05	0.000242	CcSEcCtD
Pazopanib—Malnutrition—Topiramate—epilepsy syndrome	2.12e-05	0.000242	CcSEcCtD
Pazopanib—Erythema—Topiramate—epilepsy syndrome	2.12e-05	0.000242	CcSEcCtD
Pazopanib—Headache—Oxcarbazepine—epilepsy syndrome	2.11e-05	0.000241	CcSEcCtD
Pazopanib—Nausea—Zonisamide—epilepsy syndrome	2.1e-05	0.00024	CcSEcCtD
Pazopanib—Dry mouth—Gabapentin—epilepsy syndrome	2.1e-05	0.000239	CcSEcCtD
Pazopanib—Flatulence—Topiramate—epilepsy syndrome	2.09e-05	0.000238	CcSEcCtD
Pazopanib—ABCB1—cerebellum—epilepsy syndrome	2.08e-05	0.000506	CbGeAlD
Pazopanib—Dysgeusia—Topiramate—epilepsy syndrome	2.08e-05	0.000237	CcSEcCtD
Pazopanib—Dizziness—Lamotrigine—epilepsy syndrome	2.07e-05	0.000236	CcSEcCtD
Pazopanib—Oedema—Gabapentin—epilepsy syndrome	2.06e-05	0.000235	CcSEcCtD
Pazopanib—Vomiting—Carbamazepine—epilepsy syndrome	2.06e-05	0.000234	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	2.05e-05	0.000233	CcSEcCtD
Pazopanib—Infection—Gabapentin—epilepsy syndrome	2.05e-05	0.000233	CcSEcCtD
Pazopanib—Muscle spasms—Topiramate—epilepsy syndrome	2.04e-05	0.000233	CcSEcCtD
Pazopanib—Rash—Carbamazepine—epilepsy syndrome	2.04e-05	0.000232	CcSEcCtD
Pazopanib—Dermatitis—Carbamazepine—epilepsy syndrome	2.04e-05	0.000232	CcSEcCtD
Pazopanib—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.03e-05	0.000232	CcSEcCtD
Pazopanib—Insomnia—Pregabalin—epilepsy syndrome	2.03e-05	0.000231	CcSEcCtD
Pazopanib—Nausea—Clonazepam—epilepsy syndrome	2.03e-05	0.000231	CcSEcCtD
Pazopanib—Headache—Carbamazepine—epilepsy syndrome	2.03e-05	0.000231	CcSEcCtD
Pazopanib—Shock—Gabapentin—epilepsy syndrome	2.03e-05	0.000231	CcSEcCtD
Pazopanib—Nervous system disorder—Gabapentin—epilepsy syndrome	2.02e-05	0.00023	CcSEcCtD
Pazopanib—Paraesthesia—Pregabalin—epilepsy syndrome	2.02e-05	0.00023	CcSEcCtD
Pazopanib—Thrombocytopenia—Gabapentin—epilepsy syndrome	2.02e-05	0.00023	CcSEcCtD
Pazopanib—Nausea—Phenytoin—epilepsy syndrome	2.01e-05	0.000229	CcSEcCtD
Pazopanib—Dyspnoea—Pregabalin—epilepsy syndrome	2e-05	0.000228	CcSEcCtD
Pazopanib—Nausea—Oxcarbazepine—epilepsy syndrome	2e-05	0.000228	CcSEcCtD
Pazopanib—Vision blurred—Topiramate—epilepsy syndrome	2e-05	0.000228	CcSEcCtD
Pazopanib—Skin disorder—Gabapentin—epilepsy syndrome	2e-05	0.000228	CcSEcCtD
Pazopanib—Somnolence—Pregabalin—epilepsy syndrome	2e-05	0.000228	CcSEcCtD
Pazopanib—Hyperhidrosis—Gabapentin—epilepsy syndrome	1.99e-05	0.000227	CcSEcCtD
Pazopanib—Vomiting—Lamotrigine—epilepsy syndrome	1.99e-05	0.000227	CcSEcCtD
Pazopanib—Rash—Lamotrigine—epilepsy syndrome	1.97e-05	0.000225	CcSEcCtD
Pazopanib—Dermatitis—Lamotrigine—epilepsy syndrome	1.97e-05	0.000224	CcSEcCtD
Pazopanib—Abdominal pain—Valproic Acid—epilepsy syndrome	1.96e-05	0.000224	CcSEcCtD
Pazopanib—Anorexia—Gabapentin—epilepsy syndrome	1.96e-05	0.000224	CcSEcCtD
Pazopanib—Anaemia—Topiramate—epilepsy syndrome	1.96e-05	0.000224	CcSEcCtD
Pazopanib—Headache—Lamotrigine—epilepsy syndrome	1.96e-05	0.000223	CcSEcCtD
Pazopanib—Decreased appetite—Pregabalin—epilepsy syndrome	1.95e-05	0.000222	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	1.94e-05	0.000221	CcSEcCtD
Pazopanib—Fatigue—Pregabalin—epilepsy syndrome	1.94e-05	0.000221	CcSEcCtD
Pazopanib—Nausea—Carbamazepine—epilepsy syndrome	1.92e-05	0.000219	CcSEcCtD
Pazopanib—Pain—Pregabalin—epilepsy syndrome	1.92e-05	0.000219	CcSEcCtD
Pazopanib—Syncope—Topiramate—epilepsy syndrome	1.9e-05	0.000217	CcSEcCtD
Pazopanib—Leukopenia—Topiramate—epilepsy syndrome	1.9e-05	0.000217	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	1.88e-05	0.000214	CcSEcCtD
Pazopanib—Loss of consciousness—Topiramate—epilepsy syndrome	1.87e-05	0.000213	CcSEcCtD
Pazopanib—Insomnia—Gabapentin—epilepsy syndrome	1.86e-05	0.000212	CcSEcCtD
Pazopanib—Nausea—Lamotrigine—epilepsy syndrome	1.86e-05	0.000212	CcSEcCtD
Pazopanib—Cough—Topiramate—epilepsy syndrome	1.85e-05	0.000211	CcSEcCtD
Pazopanib—Paraesthesia—Gabapentin—epilepsy syndrome	1.85e-05	0.000211	CcSEcCtD
Pazopanib—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.84e-05	0.000209	CcSEcCtD
Pazopanib—Dyspnoea—Gabapentin—epilepsy syndrome	1.84e-05	0.000209	CcSEcCtD
Pazopanib—Hypertension—Topiramate—epilepsy syndrome	1.83e-05	0.000209	CcSEcCtD
Pazopanib—Somnolence—Gabapentin—epilepsy syndrome	1.83e-05	0.000209	CcSEcCtD
Pazopanib—Dyspepsia—Gabapentin—epilepsy syndrome	1.81e-05	0.000207	CcSEcCtD
Pazopanib—Myalgia—Topiramate—epilepsy syndrome	1.81e-05	0.000206	CcSEcCtD
Pazopanib—Chest pain—Topiramate—epilepsy syndrome	1.81e-05	0.000206	CcSEcCtD
Pazopanib—Arthralgia—Topiramate—epilepsy syndrome	1.81e-05	0.000206	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	1.79e-05	0.000205	CcSEcCtD
Pazopanib—Decreased appetite—Gabapentin—epilepsy syndrome	1.79e-05	0.000204	CcSEcCtD
Pazopanib—Asthenia—Valproic Acid—epilepsy syndrome	1.78e-05	0.000203	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.78e-05	0.000203	CcSEcCtD
Pazopanib—Fatigue—Gabapentin—epilepsy syndrome	1.77e-05	0.000202	CcSEcCtD
Pazopanib—Abdominal pain—Pregabalin—epilepsy syndrome	1.77e-05	0.000202	CcSEcCtD
Pazopanib—Dry mouth—Topiramate—epilepsy syndrome	1.77e-05	0.000201	CcSEcCtD
Pazopanib—Pain—Gabapentin—epilepsy syndrome	1.76e-05	0.000201	CcSEcCtD
Pazopanib—Pruritus—Valproic Acid—epilepsy syndrome	1.76e-05	0.0002	CcSEcCtD
Pazopanib—Oedema—Topiramate—epilepsy syndrome	1.73e-05	0.000197	CcSEcCtD
Pazopanib—Infection—Topiramate—epilepsy syndrome	1.72e-05	0.000196	CcSEcCtD
Pazopanib—Shock—Topiramate—epilepsy syndrome	1.7e-05	0.000194	CcSEcCtD
Pazopanib—Diarrhoea—Valproic Acid—epilepsy syndrome	1.7e-05	0.000194	CcSEcCtD
Pazopanib—Nervous system disorder—Topiramate—epilepsy syndrome	1.7e-05	0.000194	CcSEcCtD
Pazopanib—Thrombocytopenia—Topiramate—epilepsy syndrome	1.7e-05	0.000193	CcSEcCtD
Pazopanib—ABCB1—brain—epilepsy syndrome	1.69e-05	0.000411	CbGeAlD
Pazopanib—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.68e-05	0.000192	CcSEcCtD
Pazopanib—Skin disorder—Topiramate—epilepsy syndrome	1.68e-05	0.000192	CcSEcCtD
Pazopanib—Hyperhidrosis—Topiramate—epilepsy syndrome	1.67e-05	0.000191	CcSEcCtD
Pazopanib—Anorexia—Topiramate—epilepsy syndrome	1.65e-05	0.000188	CcSEcCtD
Pazopanib—Dizziness—Valproic Acid—epilepsy syndrome	1.64e-05	0.000187	CcSEcCtD
Pazopanib—Abdominal pain—Gabapentin—epilepsy syndrome	1.63e-05	0.000186	CcSEcCtD
Pazopanib—Asthenia—Pregabalin—epilepsy syndrome	1.61e-05	0.000184	CcSEcCtD
Pazopanib—Pruritus—Pregabalin—epilepsy syndrome	1.59e-05	0.000181	CcSEcCtD
Pazopanib—Vomiting—Valproic Acid—epilepsy syndrome	1.58e-05	0.00018	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	1.58e-05	0.00018	CcSEcCtD
Pazopanib—Insomnia—Topiramate—epilepsy syndrome	1.57e-05	0.000179	CcSEcCtD
Pazopanib—Rash—Valproic Acid—epilepsy syndrome	1.57e-05	0.000179	CcSEcCtD
Pazopanib—Dermatitis—Valproic Acid—epilepsy syndrome	1.56e-05	0.000178	CcSEcCtD
Pazopanib—Headache—Valproic Acid—epilepsy syndrome	1.56e-05	0.000177	CcSEcCtD
Pazopanib—Paraesthesia—Topiramate—epilepsy syndrome	1.56e-05	0.000177	CcSEcCtD
Pazopanib—Dyspnoea—Topiramate—epilepsy syndrome	1.54e-05	0.000176	CcSEcCtD
Pazopanib—Somnolence—Topiramate—epilepsy syndrome	1.54e-05	0.000176	CcSEcCtD
Pazopanib—Diarrhoea—Pregabalin—epilepsy syndrome	1.54e-05	0.000175	CcSEcCtD
Pazopanib—Dyspepsia—Topiramate—epilepsy syndrome	1.52e-05	0.000174	CcSEcCtD
Pazopanib—Decreased appetite—Topiramate—epilepsy syndrome	1.51e-05	0.000172	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.5e-05	0.00017	CcSEcCtD
Pazopanib—Fatigue—Topiramate—epilepsy syndrome	1.49e-05	0.00017	CcSEcCtD
Pazopanib—Dizziness—Pregabalin—epilepsy syndrome	1.48e-05	0.000169	CcSEcCtD
Pazopanib—Pain—Topiramate—epilepsy syndrome	1.48e-05	0.000169	CcSEcCtD
Pazopanib—Asthenia—Gabapentin—epilepsy syndrome	1.48e-05	0.000168	CcSEcCtD
Pazopanib—Nausea—Valproic Acid—epilepsy syndrome	1.47e-05	0.000168	CcSEcCtD
Pazopanib—Pruritus—Gabapentin—epilepsy syndrome	1.46e-05	0.000166	CcSEcCtD
Pazopanib—Vomiting—Pregabalin—epilepsy syndrome	1.43e-05	0.000163	CcSEcCtD
Pazopanib—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.42e-05	0.000161	CcSEcCtD
Pazopanib—Rash—Pregabalin—epilepsy syndrome	1.42e-05	0.000161	CcSEcCtD
Pazopanib—Dermatitis—Pregabalin—epilepsy syndrome	1.41e-05	0.000161	CcSEcCtD
Pazopanib—Diarrhoea—Gabapentin—epilepsy syndrome	1.41e-05	0.000161	CcSEcCtD
Pazopanib—Headache—Pregabalin—epilepsy syndrome	1.41e-05	0.00016	CcSEcCtD
Pazopanib—Abdominal pain—Topiramate—epilepsy syndrome	1.37e-05	0.000156	CcSEcCtD
Pazopanib—Dizziness—Gabapentin—epilepsy syndrome	1.36e-05	0.000155	CcSEcCtD
Pazopanib—Nausea—Pregabalin—epilepsy syndrome	1.33e-05	0.000152	CcSEcCtD
Pazopanib—Vomiting—Gabapentin—epilepsy syndrome	1.31e-05	0.000149	CcSEcCtD
Pazopanib—Rash—Gabapentin—epilepsy syndrome	1.3e-05	0.000148	CcSEcCtD
Pazopanib—Dermatitis—Gabapentin—epilepsy syndrome	1.3e-05	0.000148	CcSEcCtD
Pazopanib—Headache—Gabapentin—epilepsy syndrome	1.29e-05	0.000147	CcSEcCtD
Pazopanib—Asthenia—Topiramate—epilepsy syndrome	1.24e-05	0.000142	CcSEcCtD
Pazopanib—Pruritus—Topiramate—epilepsy syndrome	1.23e-05	0.00014	CcSEcCtD
Pazopanib—Nausea—Gabapentin—epilepsy syndrome	1.22e-05	0.000139	CcSEcCtD
Pazopanib—Diarrhoea—Topiramate—epilepsy syndrome	1.18e-05	0.000135	CcSEcCtD
Pazopanib—Dizziness—Topiramate—epilepsy syndrome	1.15e-05	0.000131	CcSEcCtD
Pazopanib—Vomiting—Topiramate—epilepsy syndrome	1.1e-05	0.000126	CcSEcCtD
Pazopanib—Rash—Topiramate—epilepsy syndrome	1.09e-05	0.000124	CcSEcCtD
Pazopanib—Dermatitis—Topiramate—epilepsy syndrome	1.09e-05	0.000124	CcSEcCtD
Pazopanib—Headache—Topiramate—epilepsy syndrome	1.08e-05	0.000124	CcSEcCtD
Pazopanib—Nausea—Topiramate—epilepsy syndrome	1.03e-05	0.000117	CcSEcCtD
Pazopanib—FGFR3—Signaling Pathways—VEGFA—epilepsy syndrome	6.5e-07	8.81e-06	CbGpPWpGaD
Pazopanib—LYN—Immune System—JUN—epilepsy syndrome	6.49e-07	8.79e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—CCL2—epilepsy syndrome	6.49e-07	8.79e-06	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—JUN—epilepsy syndrome	6.49e-07	8.78e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—CCL2—epilepsy syndrome	6.48e-07	8.77e-06	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—MMP9—epilepsy syndrome	6.48e-07	8.77e-06	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	6.46e-07	8.75e-06	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—APOE—epilepsy syndrome	6.45e-07	8.74e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	6.44e-07	8.72e-06	CbGpPWpGaD
Pazopanib—KIT—Disease—SRC—epilepsy syndrome	6.44e-07	8.72e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	6.43e-07	8.7e-06	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—AKT1—epilepsy syndrome	6.42e-07	8.69e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—PRKCB—epilepsy syndrome	6.41e-07	8.68e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	6.39e-07	8.65e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	6.38e-07	8.64e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—IL6ST—epilepsy syndrome	6.38e-07	8.64e-06	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—CASP3—epilepsy syndrome	6.37e-07	8.63e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—YWHAZ—epilepsy syndrome	6.37e-07	8.62e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	6.35e-07	8.6e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—AKT1—epilepsy syndrome	6.35e-07	8.6e-06	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—MMP9—epilepsy syndrome	6.31e-07	8.54e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—FGF2—epilepsy syndrome	6.3e-07	8.53e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—NGF—epilepsy syndrome	6.29e-07	8.52e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	6.28e-07	8.51e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—TH—epilepsy syndrome	6.26e-07	8.48e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	6.26e-07	8.47e-06	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—AKT1—epilepsy syndrome	6.22e-07	8.42e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—BCL2—epilepsy syndrome	6.22e-07	8.42e-06	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—JUN—epilepsy syndrome	6.19e-07	8.38e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—FGF2—epilepsy syndrome	6.18e-07	8.37e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	6.16e-07	8.34e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CCR5—epilepsy syndrome	6.12e-07	8.29e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	6.12e-07	8.28e-06	CbGpPWpGaD
Pazopanib—FGFR1—Disease—SRC—epilepsy syndrome	6.11e-07	8.28e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—SRC—epilepsy syndrome	6.1e-07	8.26e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Adaptive Immune System—AKT1—epilepsy syndrome	6.1e-07	8.25e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—RELA—epilepsy syndrome	6.08e-07	8.23e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—FGF2—epilepsy syndrome	6.04e-07	8.18e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	6.03e-07	8.16e-06	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—MMP9—epilepsy syndrome	6.02e-07	8.15e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—HTR2A—epilepsy syndrome	5.99e-07	8.11e-06	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—POMC—epilepsy syndrome	5.99e-07	8.11e-06	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—SRC—epilepsy syndrome	5.97e-07	8.08e-06	CbGpPWpGaD
Pazopanib—LYN—Adaptive Immune System—AKT1—epilepsy syndrome	5.97e-07	8.08e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—POMC—epilepsy syndrome	5.96e-07	8.07e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—MTOR—epilepsy syndrome	5.96e-07	8.07e-06	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—ALB—epilepsy syndrome	5.96e-07	8.07e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—SRC—epilepsy syndrome	5.95e-07	8.06e-06	CbGpPWpGaD
Pazopanib—FGFR3—Disease—AKT1—epilepsy syndrome	5.93e-07	8.02e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—FGF2—epilepsy syndrome	5.87e-07	7.95e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—FGF2—epilepsy syndrome	5.85e-07	7.93e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—AQP1—epilepsy syndrome	5.85e-07	7.92e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—RELA—epilepsy syndrome	5.84e-07	7.91e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—POMC—epilepsy syndrome	5.84e-07	7.91e-06	CbGpPWpGaD
Pazopanib—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	5.84e-07	7.9e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CCL2—epilepsy syndrome	5.84e-07	7.9e-06	CbGpPWpGaD
Pazopanib—LYN—Immune System—SRC—epilepsy syndrome	5.83e-07	7.89e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	5.82e-07	7.89e-06	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—SRC—epilepsy syndrome	5.82e-07	7.88e-06	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—VEGFA—epilepsy syndrome	5.81e-07	7.87e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—BCHE—epilepsy syndrome	5.8e-07	7.85e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—RELA—epilepsy syndrome	5.74e-07	7.77e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—MTOR—epilepsy syndrome	5.73e-07	7.76e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CCL2—epilepsy syndrome	5.71e-07	7.74e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TSC2—epilepsy syndrome	5.69e-07	7.71e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—AGT—epilepsy syndrome	5.69e-07	7.7e-06	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—VEGFA—epilepsy syndrome	5.67e-07	7.67e-06	CbGpPWpGaD
Pazopanib—LCK—Hemostasis—AKT1—epilepsy syndrome	5.66e-07	7.66e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—MTOR—epilepsy syndrome	5.63e-07	7.62e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	5.59e-07	7.57e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—APOE—epilepsy syndrome	5.57e-07	7.54e-06	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—SRC—epilepsy syndrome	5.55e-07	7.51e-06	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—POMC—epilepsy syndrome	5.54e-07	7.51e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	5.53e-07	7.49e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—MTOR—epilepsy syndrome	5.5e-07	7.45e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—SRC—epilepsy syndrome	5.49e-07	7.44e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—IL1B—epilepsy syndrome	5.49e-07	7.44e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	5.49e-07	7.43e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PLCB1—epilepsy syndrome	5.47e-07	7.41e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—BCHE—epilepsy syndrome	5.47e-07	7.4e-06	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—ALB—epilepsy syndrome	5.46e-07	7.39e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—KDR—epilepsy syndrome	5.46e-07	7.39e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—TH—epilepsy syndrome	5.45e-07	7.38e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—PTGS2—epilepsy syndrome	5.45e-07	7.38e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—RELA—epilepsy syndrome	5.45e-07	7.38e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	5.45e-07	7.37e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—RELA—epilepsy syndrome	5.43e-07	7.36e-06	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—AKT1—epilepsy syndrome	5.43e-07	7.36e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	5.41e-07	7.33e-06	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—VEGFA—epilepsy syndrome	5.41e-07	7.32e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	5.37e-07	7.28e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—MTOR—epilepsy syndrome	5.34e-07	7.23e-06	CbGpPWpGaD
Pazopanib—FGF1—Immune System—AKT1—epilepsy syndrome	5.33e-07	7.22e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—MTOR—epilepsy syndrome	5.33e-07	7.21e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—JUN—epilepsy syndrome	5.32e-07	7.21e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	5.29e-07	7.16e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	5.29e-07	7.16e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—FGF2—epilepsy syndrome	5.27e-07	7.14e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—CASP3—epilepsy syndrome	5.27e-07	7.14e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—PRKCB—epilepsy syndrome	5.25e-07	7.11e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IL6ST—epilepsy syndrome	5.23e-07	7.08e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	5.22e-07	7.07e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	5.21e-07	7.06e-06	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—PTGS2—epilepsy syndrome	5.21e-07	7.06e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—CASP3—epilepsy syndrome	5.18e-07	7.01e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—FGF2—epilepsy syndrome	5.16e-07	6.99e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	5.16e-07	6.98e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—CAT—epilepsy syndrome	5.16e-07	6.98e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—TH—epilepsy syndrome	5.14e-07	6.96e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—JUN—epilepsy syndrome	5.12e-07	6.93e-06	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—AKT1—epilepsy syndrome	5.09e-07	6.9e-06	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—ALB—epilepsy syndrome	5.06e-07	6.84e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—JUN—epilepsy syndrome	5.03e-07	6.81e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	5.01e-07	6.79e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—MMP9—epilepsy syndrome	4.98e-07	6.75e-06	CbGpPWpGaD
Pazopanib—FGF1—Disease—AKT1—epilepsy syndrome	4.93e-07	6.67e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—CASP3—epilepsy syndrome	4.91e-07	6.65e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—CASP3—epilepsy syndrome	4.9e-07	6.64e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.9e-07	6.63e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—RELA—epilepsy syndrome	4.9e-07	6.63e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—MMP9—epilepsy syndrome	4.89e-07	6.62e-06	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—AKT1—epilepsy syndrome	4.89e-07	6.62e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	4.88e-07	6.61e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—MTOR—epilepsy syndrome	4.8e-07	6.5e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—RELA—epilepsy syndrome	4.79e-07	6.49e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—POMC—epilepsy syndrome	4.79e-07	6.48e-06	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—PTGS2—epilepsy syndrome	4.78e-07	6.47e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—SRC—epilepsy syndrome	4.78e-07	6.47e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—JUN—epilepsy syndrome	4.77e-07	6.46e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—JUN—epilepsy syndrome	4.76e-07	6.45e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—MTOR—epilepsy syndrome	4.7e-07	6.36e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CCL2—epilepsy syndrome	4.68e-07	6.34e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—GPX1—epilepsy syndrome	4.66e-07	6.31e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	4.65e-07	6.3e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—MMP9—epilepsy syndrome	4.64e-07	6.29e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—MMP9—epilepsy syndrome	4.63e-07	6.27e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—BCHE—epilepsy syndrome	4.63e-07	6.27e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—SRC—epilepsy syndrome	4.59e-07	6.22e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—HMOX1—epilepsy syndrome	4.55e-07	6.16e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—SRC—epilepsy syndrome	4.51e-07	6.11e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—CAT—epilepsy syndrome	4.49e-07	6.08e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—VEGFA—epilepsy syndrome	4.47e-07	6.06e-06	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—PTGS2—epilepsy syndrome	4.42e-07	5.99e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	4.42e-07	5.98e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CASP3—epilepsy syndrome	4.42e-07	5.98e-06	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—AKT1—epilepsy syndrome	4.41e-07	5.98e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—SRC—epilepsy syndrome	4.41e-07	5.97e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—VEGFA—epilepsy syndrome	4.39e-07	5.95e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	4.37e-07	5.92e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—TH—epilepsy syndrome	4.35e-07	5.89e-06	CbGpPWpGaD
Pazopanib—KIT—Immune System—AKT1—epilepsy syndrome	4.34e-07	5.87e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CASP3—epilepsy syndrome	4.32e-07	5.85e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	4.31e-07	5.84e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	4.29e-07	5.81e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—JUN—epilepsy syndrome	4.29e-07	5.81e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.29e-07	5.8e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—SRC—epilepsy syndrome	4.28e-07	5.8e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—SRC—epilepsy syndrome	4.27e-07	5.78e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—CAT—epilepsy syndrome	4.23e-07	5.73e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—FGF2—epilepsy syndrome	4.23e-07	5.73e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	4.2e-07	5.69e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—JUN—epilepsy syndrome	4.2e-07	5.69e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	4.18e-07	5.66e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—MMP9—epilepsy syndrome	4.17e-07	5.65e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—VEGFA—epilepsy syndrome	4.17e-07	5.65e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—VEGFA—epilepsy syndrome	4.16e-07	5.63e-06	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—AKT1—epilepsy syndrome	4.15e-07	5.62e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	4.12e-07	5.57e-06	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—AKT1—epilepsy syndrome	4.11e-07	5.57e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—AKT1—epilepsy syndrome	4.1e-07	5.56e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—AGT—epilepsy syndrome	4.09e-07	5.54e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—MMP9—epilepsy syndrome	4.09e-07	5.53e-06	CbGpPWpGaD
Pazopanib—FGFR2—Disease—AKT1—epilepsy syndrome	4.08e-07	5.52e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—GPX1—epilepsy syndrome	4.06e-07	5.5e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—APOE—epilepsy syndrome	4.01e-07	5.42e-06	CbGpPWpGaD
Pazopanib—KIT—Disease—AKT1—epilepsy syndrome	4e-07	5.42e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—RELA—epilepsy syndrome	3.93e-07	5.32e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—MTOR—epilepsy syndrome	3.85e-07	5.22e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—SRC—epilepsy syndrome	3.85e-07	5.21e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—GPX1—epilepsy syndrome	3.83e-07	5.18e-06	CbGpPWpGaD
Pazopanib—FGFR1—Disease—AKT1—epilepsy syndrome	3.8e-07	5.14e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—AKT1—epilepsy syndrome	3.79e-07	5.13e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	3.77e-07	5.1e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—SRC—epilepsy syndrome	3.77e-07	5.1e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—VEGFA—epilepsy syndrome	3.75e-07	5.07e-06	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—AKT1—epilepsy syndrome	3.71e-07	5.02e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—AKT1—epilepsy syndrome	3.7e-07	5.01e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—VEGFA—epilepsy syndrome	3.67e-07	4.97e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	3.63e-07	4.92e-06	CbGpPWpGaD
Pazopanib—LYN—Immune System—AKT1—epilepsy syndrome	3.62e-07	4.9e-06	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—AKT1—epilepsy syndrome	3.62e-07	4.9e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	3.59e-07	4.86e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CAT—epilepsy syndrome	3.59e-07	4.85e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—BCHE—epilepsy syndrome	3.57e-07	4.84e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—AGT—epilepsy syndrome	3.56e-07	4.82e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CASP3—epilepsy syndrome	3.54e-07	4.8e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—APOE—epilepsy syndrome	3.49e-07	4.72e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	3.49e-07	4.72e-06	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—AKT1—epilepsy syndrome	3.45e-07	4.67e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—JUN—epilepsy syndrome	3.44e-07	4.66e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—POMC—epilepsy syndrome	3.44e-07	4.66e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—AKT1—epilepsy syndrome	3.41e-07	4.62e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	3.41e-07	4.62e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	3.37e-07	4.57e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—TH—epilepsy syndrome	3.36e-07	4.55e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—AGT—epilepsy syndrome	3.36e-07	4.54e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—MMP9—epilepsy syndrome	3.35e-07	4.53e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—APOE—epilepsy syndrome	3.29e-07	4.45e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GPX1—epilepsy syndrome	3.24e-07	4.39e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—ALB—epilepsy syndrome	3.14e-07	4.25e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—SRC—epilepsy syndrome	3.09e-07	4.18e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—VEGFA—epilepsy syndrome	3.01e-07	4.07e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—POMC—epilepsy syndrome	3e-07	4.06e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—AKT1—epilepsy syndrome	2.97e-07	4.02e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—AKT1—epilepsy syndrome	2.85e-07	3.86e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—AGT—epilepsy syndrome	2.84e-07	3.85e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—POMC—epilepsy syndrome	2.82e-07	3.82e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	2.8e-07	3.8e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—AKT1—epilepsy syndrome	2.8e-07	3.8e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—APOE—epilepsy syndrome	2.79e-07	3.77e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CAT—epilepsy syndrome	2.77e-07	3.75e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	2.74e-07	3.72e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—AKT1—epilepsy syndrome	2.74e-07	3.71e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—ALB—epilepsy syndrome	2.73e-07	3.7e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	2.69e-07	3.64e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—AKT1—epilepsy syndrome	2.66e-07	3.6e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—AKT1—epilepsy syndrome	2.65e-07	3.59e-06	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—AKT1—epilepsy syndrome	2.62e-07	3.55e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ALB—epilepsy syndrome	2.58e-07	3.49e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GPX1—epilepsy syndrome	2.5e-07	3.39e-06	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—AKT1—epilepsy syndrome	2.4e-07	3.25e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—POMC—epilepsy syndrome	2.39e-07	3.24e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PTGS2—epilepsy syndrome	2.39e-07	3.24e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—AKT1—epilepsy syndrome	2.39e-07	3.24e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—AKT1—epilepsy syndrome	2.34e-07	3.17e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	2.25e-07	3.05e-06	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—AKT1—epilepsy syndrome	2.22e-07	3.01e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—AGT—epilepsy syndrome	2.19e-07	2.97e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ALB—epilepsy syndrome	2.18e-07	2.95e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—APOE—epilepsy syndrome	2.15e-07	2.91e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—AKT1—epilepsy syndrome	1.92e-07	2.6e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	1.91e-07	2.58e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.85e-07	2.5e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.68e-07	2.28e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.47e-07	1.99e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—AKT1—epilepsy syndrome	1.38e-07	1.87e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—AKT1—epilepsy syndrome	1.2e-07	1.63e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—AKT1—epilepsy syndrome	1.13e-07	1.53e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—AKT1—epilepsy syndrome	9.59e-08	1.3e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—AKT1—epilepsy syndrome	7.4e-08	1e-06	CbGpPWpGaD
